Literature DB >> 788668

[Attempt to treat a case of chronic familial granulomatous disease by allogenic bone marrow transplantation].

J Goudemand, R Anssens, Y Delmas-Marsalet, J P Farriaux, G Fontaine.   

Abstract

A bone marrow graft was performed in a 3 1/2 year old boy suffering from chronic granulomatous disease. Donor-recipient matching was complete in the ABO, HL-A and M.L.C. systems. The number of injected cells amounted to 5.4 X 10(9) (3.6 X 10(8) cells/kg body weight). The immunosuppression regimen consisted of cyclophosphamide and A.L.S. before the graft, and methotrexate after it. Neither graft versus host reaction, nor secondary infection developed. The take of the graft was monitored by the Gm allotypes. Rejection, however, occurred after 2 months.

Entities:  

Mesh:

Year:  1976        PMID: 788668

Source DB:  PubMed          Journal:  Arch Fr Pediatr        ISSN: 0003-9764


  5 in total

1.  A Cohort of 169 Chronic Granulomatous Disease Patients Exposed to BCG Vaccination: a Retrospective Study from a Single Center in Shanghai, China (2004-2017).

Authors:  Qinhua Zhou; Xiaoying Hui; Wenjing Ying; Jia Hou; Wenjie Wang; Danru Liu; Ying Wang; Yeheng Yu; Jingyi Wang; Jinqiao Sun; Qian Zhang; Xiaochuan Wang
Journal:  J Clin Immunol       Date:  2018-03-20       Impact factor: 8.317

2.  Myeloablative transplantation using either cord blood or bone marrow leads to immune recovery, high long-term donor chimerism and excellent survival in chronic granulomatous disease.

Authors:  Priti Tewari; Paul L Martin; Adam Mendizabal; Suhag H Parikh; Kristin M Page; Timothy A Driscoll; Harry L Malech; Joanne Kurtzberg; Vinod K Prasad
Journal:  Biol Blood Marrow Transplant       Date:  2012-02-10       Impact factor: 5.742

Review 3.  Chronic granulomatous disease 100% corrected by displacement bone marrow transplantation from a volunteer unrelated donor.

Authors:  J R Hobbs; M Monteil; D R McCluskey; E Jurges; M el Tumi
Journal:  Eur J Pediatr       Date:  1992-11       Impact factor: 3.183

4.  Chronic Granulomatous Disease; fundamental stages in our understanding of CGD.

Authors:  Tracy Assari
Journal:  Med Immunol       Date:  2006-09-21

Review 5.  Genetics and immunopathology of chronic granulomatous disease.

Authors:  Marie José Stasia; Xing Jun Li
Journal:  Semin Immunopathol       Date:  2008-05-29       Impact factor: 11.759

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.